OTCMKTS:CURLF Curaleaf (CURLF) Stock Price, News & Analysis $0.88 +0.02 (+2.53%) As of 05/20/2025 03:52 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock About Curaleaf Stock (OTCMKTS:CURLF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Curaleaf alerts:Sign Up Key Stats Today's Range$0.83▼$0.8950-Day Range$0.74▼$1.0852-Week Range$0.68▼$5.49Volume227,658 shsAverage Volume687,210 shsMarket Capitalization$580.28 millionP/E RatioN/ADividend YieldN/APrice Target$6.25Consensus RatingBuy Company OverviewCuraleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.Read More… Curaleaf Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks54th Percentile Overall ScoreCURLF MarketRank™: Curaleaf scored higher than 54% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingCuraleaf has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageCuraleaf has received no research coverage in the past 90 days.Read more about Curaleaf's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Curaleaf are expected to grow in the coming year, from ($0.25) to ($0.18) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Curaleaf is -3.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Curaleaf is -3.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCuraleaf has a P/B Ratio of 0.53. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.80% of the outstanding shares of Curaleaf have been sold short.Short Interest Ratio / Days to CoverCuraleaf has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Curaleaf has recently decreased by 8.06%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCuraleaf does not currently pay a dividend.Dividend GrowthCuraleaf does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.80% of the outstanding shares of Curaleaf have been sold short.Short Interest Ratio / Days to CoverCuraleaf has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Curaleaf has recently decreased by 8.06%, indicating that investor sentiment is improving significantly. News and Social Media1.5 / 5News Sentiment-0.27 News SentimentCuraleaf has a news sentiment score of -0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Curaleaf this week, compared to 3 articles on an average week.Search Interest6 people have searched for CURLF on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Curaleaf to their MarketBeat watchlist in the last 30 days. This is a decrease of -40% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Curaleaf insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.03% of the stock of Curaleaf is held by institutions.Read more about Curaleaf's insider trading history. Receive CURLF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Curaleaf and its competitors with MarketBeat's FREE daily newsletter. Email Address CURLF Stock News HeadlinesWhy Curaleaf Holdings Stock Topped the Market TodayMay 19 at 7:40 PM | fool.comWhat is Seaport Res Ptn's Estimate for Curaleaf Q2 Earnings?May 17, 2025 | americanbankingnews.comTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.May 21, 2025 | Porter & Company (Ad)Curaleaf Celebrates New Dispensary Opening in Lima, OhioMay 16, 2025 | prnewswire.comWhat is Cormark's Estimate for Curaleaf FY2025 Earnings?May 16, 2025 | americanbankingnews.comCuraleaf International Launches a Range of Medical Cannabis Products in AustraliaMay 15, 2025 | prnewswire.comCuraleaf International, in Partnership with Jupiter Research, Secures EU Medical Device Certification for Europe's First Handheld Liquid Inhalation DeviceMay 12, 2025 | prnewswire.comCuraleaf Holdings, Inc.: Curaleaf Reports First Quarter 2025 ResultsMay 10, 2025 | finanznachrichten.deSee More Headlines CURLF Stock Analysis - Frequently Asked Questions How have CURLF shares performed this year? Curaleaf's stock was trading at $1.56 at the start of the year. Since then, CURLF stock has decreased by 43.9% and is now trading at $0.8750. View the best growth stocks for 2025 here. How were Curaleaf's earnings last quarter? Curaleaf Holdings, Inc. (OTCMKTS:CURLF) posted its quarterly earnings results on Thursday, May, 8th. The company reported ($0.07) EPS for the quarter, hitting analysts' consensus estimates of ($0.07). Curaleaf had a negative trailing twelve-month return on equity of 13.67% and a negative net margin of 14.82%. How do I buy shares of Curaleaf? Shares of CURLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/08/2025Today5/21/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CURLF CIK1756770 Webwww.curaleaf.com Phone781-451-0351FaxN/AEmployees5,600Year FoundedN/APrice Target and Rating Average Stock Price Target$6.25 High Stock Price Target$6.25 Low Stock Price Target$6.25 Potential Upside/Downside+614.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.31) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-281,200,000.00 Net Margins-14.82% Pretax Margin-7.45% Return on Equity-13.67% Return on Assets-4.58% Debt Debt-to-Equity Ratio0.85 Current Ratio1.11 Quick Ratio0.51 Sales & Book Value Annual Sales$1.35 billion Price / Sales0.43 Cash Flow$0.09 per share Price / Cash Flow9.57 Book Value$1.64 per share Price / Book0.53Miscellaneous Outstanding Shares663,182,000Free FloatN/AMarket Cap$580.28 million OptionableNot Optionable Beta0.83 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (OTCMKTS:CURLF) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Curaleaf Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Curaleaf With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.